XML 121 R85.htm IDEA: XBRL DOCUMENT v3.21.2
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Private Warrants (Details)
12 Months Ended
Aug. 24, 2020
USD ($)
$ / shares
shares
Jul. 24, 2020
Mar. 14, 2019
USD ($)
$ / shares
Mar. 02, 2018
shares
Jun. 30, 2020
USD ($)
$ / shares
Jun. 30, 2019
USD ($)
$ / shares
INFORMATION ABOUT COMPONENTS OF EQUITY            
Private Warrants, Non-Current         $ 1,686,643 $ 2,861,511
Aggregate Number Of Shares Issued Upon Exchange Of Warrants | shares 2,601,954          
Payments For Redemption Of Warrants $ 915,796          
Exchange of warrants            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Number of outstanding warrants exchanged | shares 24,200,000          
Number Of Shares Issued Upon Exchange Of Each Warrant | shares 0.12          
Cash Consideration For Exchange Of Each Warrant | $ / shares $ 0.45          
Percentage Of Cash Consideration Provided For Premium To Closing Trading Price Of Warrants   321.00%        
Percentage Of Implied Value Of Exchange Shares Provided For Premium To Closing Trading Price Of Warrants   482.00%        
Number Of Warrants Validly Tendered But Not Properly Withdrawn | shares 21,938,774          
Aggregate Cash Consideration For Exchange Of Warrants $ 115,062          
Aggregate Number Of Shares Issued Upon Exchange Of Warrants | shares 2,601,954          
Number Of Warrants Redeemed | shares 2,261,226          
Warrants Redeemed, Offering Price Per Warrant | $ / shares $ 0.405          
Private warrants            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Warrant exercise period     5 years      
Warrants incorporate in the reverse capitalization as reduction of equity     $ 1,589,548      
Number of instruments or interests issued or issuable     12,700,000      
Financial liabilities, at fair value     $ 3,400,000   1,700,000 2,800,000
Gain recognized from change in fair value $ 6,200,000       $ 1,200,000 $ 600,000
Private warrants | Volatility            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Assumption used in estimating fair value     32      
Private warrants | Share price            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Assumption used in estimating fair value | $ / shares     5.35   6.06 5.30
Private warrants | Risk-free rate            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Assumption used in estimating fair value     2.43   0.29 1.7631
Private warrants, strike price $15.00            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Warrants strike price     15.00      
Number of instruments or interests issued or issuable     2,500,000      
Private warrants, strike price $18.00            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Warrants strike price     18.00      
Number of instruments or interests issued or issuable     2,500,000      
Founder warrants            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Warrants incorporate in the reverse capitalization as reduction of equity     $ 1,843,175      
Number of instruments or interests issued or issuable     5,200,000      
Bioceres warrants            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Number of instruments or interests issued or issuable     7,500,000      
UAC            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Number of warrants issued in IPO | shares       5,200,000    
Warrants strike price       11.50    
Warrant exercise period       5 years    
UAC | Private warrants, strike price $11.50            
INFORMATION ABOUT COMPONENTS OF EQUITY            
Warrants strike price     11.50      
Number of instruments or interests issued or issuable     2,500,000      
Share price at which warrants become exercisable | $ / shares     $ 15.00      
Number of trading days of shares at $15.00 for the warrants to vest     20      
Continuous trading period at the warrant strike price for the warrants to vest     30 days